Puma Biotechnology Stock (NASDAQ: PBYI) stock price, news, charts, stock research, profile.
Open | $4.870 |
Close | - |
Volume / Avg. | 14.291K / 573.927K |
Day Range | 4.870 - 5.030 |
52 Wk Range | 2.130 - 7.730 |
Market Cap | $241.036M |
P/E Ratio | 10.844 |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 45 |
Short Interest | 8.01% |
Days to Cover | 4.3 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Puma Biotechnology (NASDAQ: PBYI) through any online brokerage.
Other companies in Puma Biotechnology’s space includes: Zura Bio (NASDAQ:ZURA), Renovaro (NASDAQ:RENB), Galectin Therapeutics (NASDAQ:GALT), Inozyme Pharma (NASDAQ:INZY) and Inovio Pharmaceuticals (NASDAQ:INO).
The latest price target for Puma Biotechnology (NASDAQ: PBYI) was reported by HC Wainwright & Co. on Friday, March 1, 2024. The analyst firm set a price target for 7.00 expecting PBYI to rise to within 12 months (a possible 40.00% upside). 6 analyst firms have reported ratings in the last year.
The stock price for Puma Biotechnology (NASDAQ: PBYI) is $5 last updated Today at April 26, 2024 at 9:55 AM EDT.
There are no upcoming dividends for Puma Biotechnology.
Puma Biotechnology’s Q1 earnings are confirmed for Thursday, May 2, 2024.
There is no upcoming split for Puma Biotechnology.
Puma Biotechnology is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.